Arkolith/Insider Trading/ADMA/Form 4

Kestenberg-Messina Kaitlin M.

COO and SVP, ComplianceADMA BIOLOGICS, INC. (ADMA) · full profile →Form 4 · filed Aug 1, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2025Option exercise(M)3K$8.98$22K490K
Jul 30, 2025Tax withholding(F)1K$18.59$22K489K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 30, 2025Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-028449) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML